Loading clinical trials...
Loading clinical trials...
The purpose of this study is to determine whether levonorgestrel (LNG)/ethinyl estradiol (EE) is effective in treating the symptoms of severe premenstrual syndrome (PMS).
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer
NCT06724419 · Premenstrual Syndrome-PMS
NCT06297980 · Type 1 Diabetes, Hypoglycemia, and more
NCT07526623 · Premenstrual Syndrome-PMS
NCT07013539 · Premenstrual Syndrome-PMS
NCT07461051 · Premenstrual Syndrome
Scottsdale, Arizona
Tucson, Arizona
Jonesboro, Arkansas
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions